Guest: Dr. Jerry Tan
Presenter: Neal Howard
Guest Bio: Jerry Tan, M.D., fellowship certified specialist in dermatology and adjunct professor, Schulich School of Medicine and Dentistry, Department of Medicine, University of Western Ontario and principal investigator of the OSCAR trial. His academic focus is on research in acne, rosacea and hidradenitis suppurativa. His research interests are also in clinical trial outcome measures, clinical practice guidelines development and quality of life research. He is a co-recipient of grants from the NIH/NIAMS for acne core outcomes development and Pfizer Grants for Learning & Change and American Academy of Dermatology Collaboration for the development of patient decision aids. He has published over 100 peer-reviewed articles and serves on the editorial board of the British Journal of Dermatology and the Journal of the American Academy of Dermatology.
Segment Overview: Dr. Jerry Tan, M.D., board-certified dermatologist and adjunct professor at the Schulich School of Medicine and Dentistry, Department of Medicine, University of Western Ontario and principal investigator of the OSCAR trial, discusses new results from the Galderma Phase 4 OSCAR study, revealing that Epiduo Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% not only decreased acne lesions, as measured over a period of 24 weeks, but by rapidly and effectively treating acne, it also reduced the risk of atrophic acne scars in patients with moderate-to-severe acne. www.EpiduoForte.com